Level 1: Education and Information

 

In the face of any illness or life challenge—especially a diagnosis of cancer—patients and their loved ones quickly encounter a series of important questions and a compelling need for answers. This leads to a search for education and information about what to do next. Recognizing this need, The Seven Levels of Healing program begins with “Education and Information.” In the context of cancer care, there are two fundamental reasons why this is so important.

First, modern cancer treatments are highly varied and complex. Clearly understanding one’s diagnosis and treatment options can alleviate unnecessary fear, suffering, and confusion—and help to achieve the best possible outcomes.

Second, education and information are critical because until satisfactory answers are received it is impossible for patients—and their loved ones—to relax enough to allow healing to occur at deeper levels. Until the mind is comforted and reassured, stress and anxiety can interfere significantly with the basic treatment process, and prevent deeper levels of healing.

All individuals need and want varying amounts and types of information in the course of their journey. These needs and wants can also change at different times. However, it is essential to recognize and embrace the fundamental importance and ongoing benefits of patient education on the journey through cancer.

Take action: see How You Can Accomplish Level 1 Today.

Subscribe to Seven Levels of Healing® eNewsletter

< Seven Levels Overview Page  Next Level>

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health